Isabelle Rouquette
Institut universitaire du cancer de Toulouse Oncopole · 211 works · 5,287 citations · h-index 35
Top works
- Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
- Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
- Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
- Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
- Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts).
- On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
- Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung
- High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches
- New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center
- A Multicenter Blinded Study Evaluating EGFR and KRAS Mutation Testing Methods in the Clinical Non–Small Cell Lung Cancer Setting—IFCT/ERMETIC2 Project Part 1
- Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program
- Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
- Characteristics of lung cancer in women: Importance of hormonal and growth factors
- French multicentric validation ofALKrearrangement diagnostic in 547 lung adenocarcinomas
- Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.
- Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
- Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease.
- DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients